300086 Honz Pharmaceutical
- 5.42
- +0.21+4.03%
About Honz Pharmaceutical Company
The company is a listed enterprise focusing on children's health. It is a national high-tech enterprise, and has pioneered the establishment of an enterprise postdoctoral research workstation with children's medicine as the main research direction. The company adheres to the corporate tenet of “good medicine, bless humanity”, actively implements the “Children's Health Strategy” and “Quality Strategy”, and ingeniously builds a national brand in the children's health industry. The company is a leading domestic children's health enterprise whose main business is the R&D, production and sales of children's medicines, maternal and child health products, and medical devices such as medical protective equipment. Main products: Respiratory medicine, digestive medicine, anti-allergic drugs, antibiotics, nutritional supplements, antibacterial and antiviral drugs, antipyretic and analgesic drugs, gynecological drugs, masks, etc. Corporate honors: Top 500 Asian Brands, the 8th Hainan Excellent Enterprise, etc. Won the honorary certificate of “Guangdong High-tech Product”, the title of “Top 100 Pharmaceutical Digital Brands”, “2022 Growth Potential Star” Company, “Leading Force - High-Quality Pharmaceutical Development Achievement Enterprise in China”, the 2023 Hainan Top 40 Manufacturing Enterprises List, the “Health Industry's Most Growing Listed Company” Award, the 2023 “Excellent ESG Case of Hainan Listed Companies”, the “2023 Haikou 'Trade Union Cup' Pharmaceutical Industry Worker Labor Skills Competition - Second Prize in the Chemical Inspection and Operation Skills Competition”, and “Guangdong Provincial Enterprise Technology Honors such as “Center” and “Famous Brand Product of Guangdong Province”.
Company Profile
Company Executives
- Name
- Position
- Salary
- jiangyou hong
- Chairman, Directors, Audit Committee Members, Member of the Remuneration and Assessment Committee, Chairman of the Strategy Committee, Nomination Committee Members
- 542.00K
- liping hong
- Vice Chairman, Directors, VP, Strategy Committee Member, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- 425.70K
- youquan li
- Directors
- 180.00K
- dongxiong hong
- Directors, Audit Committee Member, Strategy Committee Member
- 138.90K
- zhihui hong
- Directors
- 46.50K
- qinghe wu
- Independent Directors, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members, Strategy Committee Member, Audit Committee Member
- 90.00K
- jicheng zhang
- Independent Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
- 90.00K
- canhui fang
- Independent Directors
- --
- huanxue zheng
- Independent Directors, Member of the Remuneration and Assessment Committee, Nomination Committee Members, Strategy Committee Member, Chairman of the Audit Committee
- 90.00K
- dexin lin
- Board Secretary, VP
- 374.50K
- fangmei lu
- Securities Affairs Representative
- --
- hongchang gao
- Chairman of the Supervisory Board, Employee Supervisors
- 382.10K
- mengke sun
- Auditors
- 112.30K
- chunying wang
- Auditors
- 12.00K
- jiangtao hong
- President
- 411.90K
- dingfu han
- Chief Financial Officer
- --
- bingchen shao
- Head of Audit and Inspection Department
- --
- yong wang
- Assistant to the Chairman (Vice President level)
- 324.00K
Analysis
Price Target
No Data
No Data